世界のプロテオミクス（タンパク質研究）市場動向及び予測（～2018）...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 23)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size Estimation
1.5.2 Market Crackdown & Data Triangulation
1.5.3 Market Share Estimation
1.5.4 Keydata Points From Secondary Sources
1.5.5 Key Data Points From Primary Sources
1.5.6 Assumptions

2 Executive Summary (Page No. – 35)

3 Premium Insights (Page No. – 42)
3.1 Growth In Personalized Medicine Market To Boost Proteomics Market
3.2 Availability Of Funds From Both Public And Private Sector To Propel Proteomics Research
3.3 Spur In Mass Spectrometry-Based Proteomic Approaches To Fuel Market Growth
3.4 High-Growth Potential Of Emerging Asian Markets In Proteomics
3.5 Proteomics Services Market Segment Presents Significant Growth Opportunities

4 Market Overview (Page No. – 49)
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Key Market Drivers
4.3.1.1 Increasing Appetite For Personalized Medicine In Healthcare Driving The Demand For Proteomic Technologies
4.3.1.2 Proteomics Bridges The Gap Between Genome Sequence And Cellular Behavior
4.3.1.3 Increasing Pharmaceutical And Biotech R&D Expenditure To Boost The Proteomics Market
4.3.1.4 Technological Advancements To Spur The Proteomics Market
4.3.1.5 Availability Of Government And Private Funding To Propel Proteomics Research
4.3.2 Key Market Restraints
4.3.2.1 Sequestration Cuts In The U.S Leading To Reduced Funds For Proteomic Research In The North American Market
4.3.2.2 Huge Disconnect Between Biomarker Discovery And Biomarker Approval By Regulatory Authorities
4.3.2.3 Expensive Tools And Instruments And Their Maintenances Involved In Proteomics Leading To Lower Adoption Rates
4.3.2.4 Need For Well-Qualified Researchers And Mandatory Training In Proteomics Increases Cost
4.3.3 Key Market Opportunities
4.3.3.1 Growing Applications Of Nanotechnology In Proteomics Research To Improve Quality Of Outcomes
4.3.3.2 Biomarker Identification Presents Significant Opportunities
4.3.3.3 Untapped Emerging Markets Present Significant Opportunities
4.3.4 Key Market Trends
4.3.4.1 Shift From Genomics To Proteomics
4.3.4.2 Integration Of Various Universities & Research Laboratories With Suppliers
4.3.4.3 High-Content Proteomics Through Integration Of Proteomics Techniques
4.4 Market Share Analysis
4.4.1 Proteomics Instrumentation Technology
4.4.2 Proteomics Reagents
4.4.3 Proteomics Services

5 Proteomics Instrumentation Technology (Page No. – 67)
5.1 Introduction
5.1.1 Protein Microarray
5.1.1.1 Biochips
5.1.1.1.1 Protein Chips
5.1.1.1.2 Lab-On-Chips (Microfluidics)
5.1.1.2 Microarray Instruments
5.1.1.2.1 Integrated Systems
5.1.1.2.2 Arrayers
5.1.1.2.3 Microarray Scanners
5.1.2 Spectroscopy
5.1.2.1 Mass Spectrometry
5.1.2.2 NMR Spectroscopy
5.1.2.3 Circular Dichroism (CD) Spectroscopy
5.1.3 X-Ray Crystallography
5.1.4 Chromatography
5.1.4.1 HPLC Systems
5.1.4.2 Ion Chromatography
5.1.4.3 Affinity Chromatography
5.1.4.4 Supercritical Fluid Chromatography
5.1.5 Electrophoresis
5.1.5.1 Gel Electrophoresis
5.1.5.2 Capillary Electrophoresis
5.1.6 Surface Plasmon Resonance (SPR) Systems
5.1.7 Protein Fractionation Systems

6 Proteomics Reagents Market (Page No. – 120)
6.1 Introduction
6.2 Microarray
6.3 Spectroscopy
6.4 X-Ray Crystallography
6.5 Chromatography
6.6 Electrophoresis
6.7 Immunoassay
6.8 Protein Fractionation Reagents

7 Proteomics Services Market (Page No. – 136)
7.1 Introduction
7.2 Analytical Laboratory Services
7.2.1 Protein Identification
7.2.2 Protein Separation
7.2.3 Protein Sequencing
7.3 Data Analysis & Maintenance
7.3.1 Bioinformatics Databases
7.3.2 Bioinformatics Tools

8 Proteomics Applications Market (Page No. – 156)
8.1 Introduction
8.2 Drug Discovery
8.3 Clinical Diagnosis
8.4 Others

9 Geographic Analysis (Page No. – 165)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 Italy
9.3.4 U.K.
9.3.5 Spain
9.4 Asia
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Rest Of Asia
9.5 Rest Of The World
9.5.1 Latin America
9.5.2 Middle East And Africa
9.5.3 Pacific Countries

10 Competitive Landscape (Page No. – 250)
10.1 Introduction
10.2 New Product Launches
10.3 Agreements, Collaborations, And Partnerships
10.4 Mergers And Acquisitions
10.5 Expansions
10.6 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 261)
11.1 Thermo Fisher Scientific Inc.
11.2 Agilent Technologies, Inc.
11.3 Bio-Rad Laboratories, Inc.
11.4 Luminex Corporation
11.5 Danaher Corporation
11.6 GE Healthcare
11.7 Waters Corporation
11.8 Affymetrix Inc.
11.9 Perkinelmer, Inc.
11.10 Sigma-Aldrich Corp

*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

Appendix (Page No. – 387)